Safety of Adjuvant Endocrine Therapies in Hormone Receptor–Positive Early Breast Cancertissues
Abstract
Share and Cite
Sehdev, S.; Martin, G.; Sideris, L.; Lam, W.; Brisson, S. Safety of Adjuvant Endocrine Therapies in Hormone Receptor–Positive Early Breast Cancertissues. Curr. Oncol. 2009, 16, 14-23. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v16i0.457
Sehdev S, Martin G, Sideris L, Lam W, Brisson S. Safety of Adjuvant Endocrine Therapies in Hormone Receptor–Positive Early Breast Cancertissues. Current Oncology. 2009; 16(s1):14-23. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v16i0.457
Chicago/Turabian StyleSehdev, S., G. Martin, L. Sideris, W. Lam, and S. Brisson. 2009. "Safety of Adjuvant Endocrine Therapies in Hormone Receptor–Positive Early Breast Cancertissues" Current Oncology 16, no. s1: 14-23. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v16i0.457